Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | GABRP | O00591 | 2/20 | 0.48 |
| ▸ | GABRD | O14764 | 2/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.48 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.48 |
| ▸ | GABRE | P78334 | 2/20 | 0.48 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.48 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.48 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.48 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.48 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.39 |
| ▸ | KDM4A | O75164 | 2/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6300743 | 0.87 | CYP1A2 (0.45) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL6295117 | 0.85 | FFAR4 (0.48) | CYP1A2ENPEPFFAR4FFAR1 | |
| SCHEMBL2169058 | 0.84 | CYP1A2 (0.62) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL6295983 | 0.84 | FFAR4 (0.52) | FFAR4FFAR1 | |
| SCHEMBL4421081 | 0.82 | CYP1A2 (0.38) | CYP1A2 | |
| SCHEMBL10254859 | 0.82 | CYP1A2 (0.60) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL712283 | 0.82 | CYP1A2 (0.60) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL10400730 | 0.80 | CYP1A2 (0.58) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL12438356 | 0.80 | CYP1A2 (0.58) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL27748155 | 0.78 | TSHR (0.48) | CYP1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117357503-B | Use of p-hydroxyphenylacetamide in the treatment of psychotic disorders | 中国人民解放军军事科学院军事医学研究院 | 2024-03-08 | — | — | CN | disclosed |
| CN-117357503-A | Use of p-hydroxyphenylacetamide in the treatment of psychotic disorders | 中国人民解放军军事科学院军事医学研究院 | 2024-01-09 | — | — | CN | disclosed |
| EP-2135614-A1 | Intestinal dismicrobism compound having anti-diarrhoea, anti-inflammatory and lactose and lactose derivative intolerance lenitive properties | EURITALIA S.r.l. (IT) | 2009-12-23 | — | — | EP | disclosed |
| US-6964787-B2 | Method and system for reducing microbial burden on a food product | ECOLAB INC. (US) | 2005-11-15 | — | — | US | disclosed |
| US-6927237-B2 | Two solvent antimicrobial compositions and methods employing them | ECOLAB INC. (US) | 2005-08-09 | — | — | US | disclosed |
| US-20050096245-A1 | Two solvent antimicrobial compositions and methods employing them | ECOLAB INC. (US) | 2005-05-05 | — | — | US | disclosed |
| US-20020192340-A1 | Method and system for reducing microbial burden on a food product | ECOLAB USA INC. | 2002-12-19 | — | — | US | disclosed |
| US-20020168422-A1 | Two solvent antimicrobial compositions and methods employing them | ECOLAB USA INC. | 2002-11-14 | — | — | US | disclosed |
| WO-2002060280-A2 | METHOD AND SYSTEM FOR REDUCING MICROBIAL BURDEN ON A FOOD PRODUCT BY APPLICATION OF ANTIMICROBIAL AGENT AND IRRADIATION TO THE FOOD PRODUCT | ECOLAB INC. (US) | 2002-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020168422-A1 | Two solvent antimicrobial compositions and methods employing them | TAS2R50, HDHD5, CEL | CYP1A2 630/4885GABRP 3248/4885GABRD 3180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.